Changes in the clinical profile of patients treated with oral anticoagulants during the decade of the ninety;Cambios en el perfil clínico de los pacientes anticoagulados durante la década de los noventa

Revista Espanola de Cardiologia

Volumn 55, Issue 1, 2002, Pages 55-60

  Ruiz de Castroviejo, Eduardo Vázquez ^a   Martín Barranco, María José ^a   Martín Rubio, Antonio ^a   Fajardo Pineda, Antonio ^a   Lozano Cabezas, Cristóbal ^a   Guzmán Herrera, Manuel ^a   Tarabini Castellani, Ada ^a   Pagola Vilardebó, Carlos ^a   Martínez Galiano, Eufrasio ^a   Alcalá Muñoz, Antonio ^a  

^a Hosp Univ Ciudad de Jaén   (Spain)

Author keywords

Anticoagulants; Atrial fibrillation; Population

Indexed keywords

ANTICOAGULANT AGENT;

AGED; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; PRESCRIPTION; STATISTICS; THROMBOEMBOLISM; ADULT; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; HEART DISEASE; HEART VALVE PROSTHESIS; MAJOR CLINICAL STUDY; MORBIDITY; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; SECONDARY PREVENTION; TREATMENT INDICATION;

AGED; ANTICOAGULANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG; THROMBOEMBOLISM;

EID: 2242422509     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-8932(02)76553-6     Document Type: Article

References (38)

1. Studies on the hemorrahagic sweet clover diesease, IV: The isolation and crystallization of the hemorrhagic agent
2. Studies on the hemorrhagic sweet clover disease, V: Identification and synthesis of the hemorrhagic agent
3. A preparation from spoiled sweet clover wich prolongs coagulation and prothombin time of the blood: Preliminary reports of experimental and clinical studies
4. The discovery of dicumarol and its sequels
5. National patterns of warfarin use in atrial fibrillation
6. Recent national patterns of warfarin use in atrial fibrillation
7. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation. Stroke Prevention in Atrial Fibrillation II study
8. The risk for and severity of bleeding complications in elderly patients treated with warfarin
9. Oral anticoagulation treatment in the elderly: A nested, prospective, case-control study
10. Atrial fibrillation as an independent risk factor for stroke: The Framingham study
11. Atrial fibrillation in an elderly population
12. Prevalence of cardiovascular disease and diabetes in residents of Rochester, Minnesota
13. Prevalence of atrial fibrillation in elderly subjects: The Cardiovascular Health Study
14. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation
15. Canadian Atrial Fibrillation Anticoagulation (CAFA) study
16. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
17. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
18. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in atrial fibrillation III randomised clinical trial
19. Utilization del tratamiento anticoagulante en los pacientes con fibrilación auricular no reumática
20. Tratamiento antitrombótico en la fibrilación auricular no reumática. ¿Cumplimos las recomendaciones de los ensayos clínicos?
21. Análisis de los factores asociados con la indicación de tratamiento anticoagulante en la fibrilaciíon auricular crónica. Estudio prospectivo de 170 pacientes ingresados en un servicio de medicina interna
22. Fibrilación auricular y anticoagulación. Experiencia del servicio de Geriatria del HU de Getafe
23. Tratamiento preventivo de la fibrilación auricular no reumática: De la eficacia de los ensayos clínicos a la efectividad en la práctica clínica
24. Tratamiento anticoagulante: Nuevos aspectos de una antigua terapia
25. Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation
26. Why do patients with atrial fibrillation not recieve warfarin?
27. Anticoagulation for patients with atrial fibrillation and risk factors for stroke. Warfarin reduces the risk for two thirds, but doctors still aren't prescribing it enough
28. Situación actual del control de la anticoagulación oral en atención primaria
29. Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: A randomized, controlled trial
30. State-of-the-art patient self-management for control of oral anticoagulation
31. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation
32. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: A randomized cross-over comparison
33. Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
34. Accidentes hemorrágicos durante el tratamiento ambulatorio prolongado con acenocumarol
35. Complicaciones hemorrágicas del tratamiento anticoagulante. Análisis de factores predictores de riesgo
36. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis
37. Guías de actuación clínica de la Sociedad Española de Cardiología. Recomendaciones para el uso del tratamiento antitrombótico en cardiología